Sarah Spruyt Pharma & Care SRL
Sarah Spruyt Pharma & Care reported total assets of 58,307 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Mar 2026).
The score of Sarah Spruyt Pharma & Care shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Sarah Spruyt Pharma & Care's annual accounts
| 2025 | |
|---|---|
| Net result | 24,166 € |
| Equity | 30,166 € |
| Cash | 19,042 € |
| EBITDA | 37,413 € |
| Total assets | 58,307 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Mar 2026
Sarah Spruyt Pharma & Care's financial analysis
- Solvency51.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Sarah Spruyt Pharma & Care
Sarah Spruyt Pharma & Care's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1015.285.043
- VAT number
- BE1015285043
- Peppol
- Registered · 0208:1015285043 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Oct 2024
- Registered office
- 2800 Mechelen
- Latest accounts
- 2025 · filed on 16 Mar 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Sarah Spruyt Pharma & Care (SRL) has been based in Mechelen since 2024, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 24,166 € and equity of 30,166 €; its revenue is not published. Its solvency stands at 51.7%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Sarah Spruyt Pharma & Care
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Pharmaes Retail sale of pharmaceutical products Anderlecht · balance sheet 57,673 €
- Charlotte Slabbinck Retail sale of pharmaceutical products Oudenburg · balance sheet 72,938 €
- P.H.A. Retail sale of pharmaceutical products Anderlecht · balance sheet 60,047 €
- REAN Retail sale of pharmaceutical products Ternat · balance sheet 60,193 €
- Pharmayat Retail sale of pharmaceutical products Auderghem · balance sheet 60,904 €
- Apotheek A. Janssens Retail sale of pharmaceutical products Maasmechelen · balance sheet 55,793 €
- Pharmacien Independant Pierre Burniaux Retail sale of pharmaceutical products Philippeville · balance sheet 61,668 €
Frequently asked questions about Sarah Spruyt Pharma & Care
What is the revenue of Sarah Spruyt Pharma & Care?
Sarah Spruyt Pharma & Care files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Sarah Spruyt Pharma & Care?
In Belgium, the VAT number is the company number prefixed with BE: BE1015285043 for Sarah Spruyt Pharma & Care, if the company is VAT-registered. Its company number (CBE) is 1015.285.043.
Where is the registered office of Sarah Spruyt Pharma & Care?
According to the CBE register, the registered office of Sarah Spruyt Pharma & Care is in 2800 Mechelen.
What is the equity of Sarah Spruyt Pharma & Care?
At the close of the 2025 financial year, the equity of Sarah Spruyt Pharma & Care amounts to 30,166 €, a solvency of 51.7% of total assets.
Who manages Sarah Spruyt Pharma & Care?
The register lists 1 active mandates at Sarah Spruyt Pharma & Care. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Sarah Spruyt Pharma & Care
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →